Pharmaceuticals

Big pharma’s cash pull-out lands blow to UK economy

Merck’s decision to scrap a £1bn investment follows the health secretary’s refusal to negotiate UK drug prices

Mandelson came to praise Brexit. Merck just buried it

Last week, the then ambassador to the US said that Brexit allowed Britain to get closer to the US – just as the drugs company withdrew billions of dollars of investment from the UK

Eli Lilly joins big pharma fallout over drug prices

Select committee calls emergency meeting as CEOs ‘livid with the UK’ after talks with government crash over NHS rebates

Alarm over ‘substitutes’ sold on black market as Mounjaro price bloats

Online sellers have started promoting weight-loss treatments that are yet to receive clinical approval